IDEAYA Biosciences, Inc.
IDYA
$25.00
$0.140.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.84% | -82.40% | -283.78% | -88.85% | -88.97% |
| Total Depreciation and Amortization | 12.40% | 4.71% | -37.21% | -1.36% | 9.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.57% | 323,050.00% | 395.55% | 122.02% | 42.12% |
| Change in Net Operating Assets | -70.65% | 179.76% | -58.30% | 58.56% | 280.26% |
| Cash from Operations | -89.99% | -37.73% | -412.27% | -63.17% | 1.73% |
| Capital Expenditure | 31.86% | -0.38% | -31.50% | 24.21% | -10.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.01% | 123.01% | -76.42% | -137.69% | 157.70% |
| Cash from Investing | -33.02% | 122.55% | -76.08% | -139.02% | 156.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.92% | -92.51% | -97.94% | 895.56% | -74.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -96.92% | -92.51% | -98.05% | 929.33% | -79.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.51% | 193.72% | -6,173.63% | 343.27% | 106.66% |